User A DATA
1. Contact address(Person who provides information. This information will be treated confidentially)?
Title: xxxx
Name: xxxx
Address: xxxx
Institution: xxxx
Telephone: xxxxx
Email : xxxxx
2. What is the source of your information about human xenotransplantation practices?
Publication
3. What is the therapeutic purpose of this xenotransplantation treatment?
a. Acute liver failure
4. Where and when is this human xenotransplantation practice taking place?
Country: xxxx
Timing: xxxx
Comment: xxxx
5. Is this treatment part of a clinical trial?
Yes
6. What is the animal source of the xenotransplantation product?
ii. Non-human primate
7. Source animals
Do you have information about source animals? Yes
8. Testing of safety
Do you have information about testing of safety? No
9. What type of cells was transplanted?
Purkinje cells
What type of tissues was transplanted?
Skin
What type of organs was transplanted?
Lung
10. What type of exposure to xenogeneic cells was involved?
Solid-organ xenotransplantation: Yes
Cellular xenotransplantation: No
Tissue xenotransplantation: Yes
Human cells exposed to xenogeneic Feeder cell: No
Extracorporeal perfusion: Yes
Encapsulation: Yes
Other bioartificial isolation device: No
11. Transplant recipient
Do you have information about transplant recipients? Yes
How are the transplant recipients being monitored for infections?
xxxxxx
Which microbial agents have been tested in transplant recipients?
xxxxxxx
Has this microbiological testing been done by a registered laboratory?
Yes.XXXXX
What testing methods were used?
Immunohistopathology
What samples are taken and how often?
XXXXXX
For how long will they continue to be taken?
XXXXXX
For how long will they be stored?
XXXXX
How often is the patient seen for follow-up?
XXXXXX
How long are the patients followed?
XXXXX
Location of the clinical follow-up examination:
In the same clinic? Yes.which xxx
12. Have results been presented at a scientific congress?
Yes.xxxx
13. Have results been published in a scientific journal?
Yes. the reference
14. Is this human clinical trial performed with governmental and/or institutional oversight and supervision?
Yes.XXXX
15. Was the trial approved by a public health authorities(ministry of health, governmental agency…)?
Yes.xxxx
16.Was the trial overseen by a public health authorities(ministry of health, governmental agency…)?
Yes.xxxx
17. Comment
xxxxxxxxxxxx